Combinational use of DNMT1 inhibitor and HDAC inhibitor is more effective on acute myeloid leukaemia and advanced Ewing's sarcoma (compared with single inhibitor used)39, 40. The gene discussed is HDAC9; the disease is acute myeloid leukemia.